COTILLI, GIULIA
COTILLI, GIULIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.006 secondi).
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
2024 Carpenedo, M; Zappaterra, A; Del Castello, L; Ferrari, B; Cotilli, G; Bernasconi, D; Pezzatti, S; Sacco, F; Borin, L; Carrer, A; Verga, L; Brioschi, F
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi
2023 Zamprogna, G; Frustaci, A; Travi, G; Borella, C; Reda, G; Motta, M; Deodato, M; Bossi, E; Mattiello, V; Ferrari, M; Cotilli, G; Gambacorti-Passerini, C; Cairoli, R; Puoti, M; Tedeschi, A
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy?
2022 Deodato, M; Frustaci, A; Zamprogna, G; Cotilli, G; Cairoli, R; Tedeschi, A
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience | 01 - Articolo su rivista | 2024 | Zappaterra A.Del Castello L.Cotilli G.Bernasconi D. P. + | |
| Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi | 01 - Articolo su rivista | 2023 | Borella C.Bossi E.Ferrari M. B.Cotilli G.Gambacorti-Passerini C.Cairoli R.Puoti M. + | |
| Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy? | 01 - Articolo su rivista | 2022 | Cotilli G.Cairoli R. + |